NFKB1 and rheumatoid arthritis: This beneficial effect is believed to be mediated, at least in part, by the inhibition of both the NF–κB and mitogen-activated protein kinase (MAPK) signaling pathways, which are key players in the inflammatory cascade associated with rheumatoid arthritis [40].